GLP-1 Drugs and SGLT-2 Inhibitors Linked to Slower Kidney Decline
Reported analysis associates both drug classes with reduced loss of kidney function, adding to evidence beyond glycemic and weight effects.
PR
By Priya Raman · Science Reporter
Sep 17 00:07 ETSource: News-Medical
The wire
- 01Research reported by News-Medical links GLP-1 receptor agonists and SGLT-2 inhibitors to slower kidney function decline.
- 02Renal protection would broaden the clinical rationale for both classes in diabetes and chronic kidney disease.
- 03Study design, population size and effect magnitude were not specified in the excerpt.
From the source
Read at news.google.comGLP-1 drugs and SGLT-2 inhibitors linked to slower kidney decline